Studies that accept IgM and/or IgG ELISA testing equally with these methods have a reduced confidence on the basis of evidence that detection of IgG and IgM can occur across a wide range of time points ranging from early in an infection and after resolution of acute illness. This evidence concerns the gene CD40LG and infection.